IOBCF (Ion Beam Applications) Moat Score: 5/10 (As of Jun. 25, 2026)


IOBCF Ion Beam Applications SA IOBCF
82 GF Score
Price $18.90
GF Value $18.71
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Ion Beam Applications Moat Score?

Ion Beam Applications IOBCF +2.18% 82 Moat Score is 5 as of Jun. 25, 2026. GuruFocus rates IOBCF with a GF Score™ of 82/100 and a GF Value™ of $18.71 (Fairly Valued). The stock has 10 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Ion Beam Applications ranks better than 91.13% on this metric.

Ion Beam Applications has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Ion Beam Applications has Narrow Moat: Ion Beam Applications SA has a solid narrow moat due to its specialized technology in proton therapy systems, which provides a modest barrier to entry. The company benefits from valuable intellectual property and a strong brand in a niche market, but lacks significant network effects or customer switching costs to elevate it to a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Ion Beam Applications might have Narrow Moat - Solid narrow moat.

Ion Beam Applications  (OTCPK:IOBCF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Ion Beam Applications Moat Score Related Terms

IOBCF vs ABT, SYK, MDT: Moat Score Comparison

For the Medical Devices subindustry, Ion Beam Applications's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ion Beam Applications Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's Moat Score distribution charts can be found below:

* The bar in red indicates where Ion Beam Applications's Moat Score falls into.


IOBCF
82GF Score
Ion Beam Applications SA IOBCF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Ion Beam Applications (IOBCF) has a Moat Score of 5 as of Jun. 25, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Ion Beam Applications ranks #75 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 8.9%.
Is Ion Beam Applications' Moat Score too high?
Ion Beam Applications' current Moat Score is 5. Based on the distribution chart, Ion Beam Applications ranks #75 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ion Beam Applications has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ion Beam Applications' Moat Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ion Beam Applications ranks #75 out of 846 companies for Moat Score. This places Ion Beam Applications in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Ion Beam Applications's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ion Beam Applications stock overvalued right now?
Based on GuruFocus' analysis, Ion Beam Applications (IOBCF) is currently considered Fairly Valued. The stock's GF Value™ is $18.71, compared to a current price of $18.90 — trading 1% above its estimated fair value. The current Moat Score is 5. Ion Beam Applications' overall GF Score™ is 82/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Ion Beam Applications (IOBCF), the current Moat Score is 5 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ion Beam Applications (IOBCF) Overvalued in 2026?

Based on GuruFocus' analysis, Ion Beam Applications stock appears to be overvalued. The current stock price of $18.90 is trading 1% above its estimated GF Value™ of $18.71. GuruFocus considers Ion Beam Applications to be Fairly Valued.

Key valuation signals for IOBCF:

  • Moat Score: 5
  • GF Value™: $18.71 vs. price of $18.90 (1% above fair value)
  • GF Score™: 82/100 with 10 warning signs

No single metric tells the full story. See the IOBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ion Beam Applications Business Description

Address Chemin du Cyclotron, 3, Louvain-La-Neuve, BEL, B-1348
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in three segments: IBA Clinical, including Proton Therapy and Dosimetry; IBA Technologies; and IBA Corporate. Proton therapy and other accelerators contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, China, Germany, and India.
82GF Score

Get the complete analysis for IOBCF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.90
Price
$18.71
GF Value